DiCE Molecules SV, LLC Company Profile

16:45 EDT 17th August 2018 | BioPortfolio

DiCE Molecules is a privately held company focused on the development of small molecule compounds that unlock previously intractable targets. DiCE’s platform uniquely brings the full power of directed evolution to the field of medicinal chemistry for the first time. The company is focused on leveraging its capabilities to create a self-financing business generating returns for its shareholders through the achievement of milestones and revenues secured by collaborations while advancing its internal drug discovery efforts. For more information, visit

News Articles [171 Associated News Articles listed on BioPortfolio]

Global Warming Rolls Dice on MI; TAVR 'Failure to Rescue'; BVS Decline

(MedPage Today) -- A bevy of studies to note from ACC while awaiting the late-breakers

La AFGE respalda a Andrew Janz de California para el Congreso

El mayor sindicato de empleados federales dice que Janz luchará por los trabajadores de servicios públicos  WASHINGTON, 11 de abril de 2018 /PRNewswire-HISPANIC PR Read more...

Encuesta de Parsons revela brechas graves de ciberseguridad en infraestructura

" Miles dedispositivos en red instalados en complejos de infraestructura crítica están mejorando su eficiencia operativa, pero aumentando el ciberriesgo", dice Carey Smith, Read more...

Less is more when it comes to predicting molecules’ conductivity

Dicer is not rolling dice

Researchers keep discovering new functions of small RNAs. For instance, they can be used as a defense mechanism against viruses or self-replicating genome invaders. These tiny pieces of RNA are often ...

Iniciativa Cal 3 aprobada para votación en todo el estado en noviembre

"Este hito es testimonio del vigoroso espíritu de los californianos que quieren crear un futuro mejor para ellos mismos y para sus comunidades", dice Peggy Read more...

Researchers screen molecules that could be potential target for prostate cancer treatments

Cancer researchers at the University of Bath have measured systematically how efficient molecules are at suppressing the activity of a protein associated with prostate and other cancers. The molecules...

Dungeons and Dragons, Not Chess and Go: Why AI Needs Roleplay

Everyone had died—not that you’d know it, from how they were laughing about their poor choices and bad rolls of the dice. As a social anthropologist, I study how people understand artificial intel...

Drugs and Medications [11 Associated Drugs and Medications listed on BioPortfolio]

Voluven [Hospira Inc.]

These highlights do not include all the information needed to use Voluven safely and effectively. See full prescribing information for Voluven. VOLUVEN (6% HYDROXYETHYL STARCH 130/0.4 IN 0.9% SODIUM C...

Vinoperfect day perfecting spf 15 [Caudalie USA Inc.]


Clarins super restorative day [Laboratoires Clarins S.A.]

Clarins Super Restorative Day

Cupriminecapsules(penicillamine) [Merck & Co., Inc.]


Immortelle brightening shield and sunscreen spf 40 [L'Occitane SA]

Immortelle Brightening Shield And Sunscreen SPF 40

PubMed Articles [652 Associated PubMed Articles listed on BioPortfolio]

Clinicopathologic significance of HLA-G and HLA-E molecules in Tunisian patients with ovarian carcinoma.

The human leukocyte antigen (HLA)-G and HLA-E, non classical HLA class I molecules, have been highly implicated in immune tolerance. HLA-G and HLA-E molecules were proposed as putative markers of seve...

Erratum: Antonsen, S.; et al. Synthesis of Racemic β-Chamigrene, a Spiro5.5undecane Sequiterpene. Molecules 2014, 19, 20664-20670.

The Molecules Editorial Office wishes to make the following erratum to this paper [1].[...].

Extent of BOLD Vascular Dysregulation Is Greater in Diffuse Gliomas without Isocitrate Dehydrogenase 1 R132H Mutation.

Purpose To determine the effect that R132H mutation status of diffuse glioma has on extent of vascular dysregulation and extent of residual blood oxygen level-dependent (BOLD) abnormality after surgic...

DiCE: Diastereomeric in-silico Chiral Elucidation, Expanded DP4 Probability Theory Method for Diastereomer and Structural Assignment.

NMR chemical shift prediction at the B3LYP/cc-pVDZ level of theory was used to develop a highly accurate probability theory algorithm for determination of stereochemistry of diastereomers as well as r...

3D high resolution imaging for microelectronics: A multi-technique survey on copper pillars.

In microelectronics, recently developed 3D integration offers the possibility to stack the dice or wafers vertically instead of putting their different parts next to one another, in order to save spac...

Clinical Trials [342 Associated Clinical Trials listed on BioPortfolio]

Chidamide Plus DICE Regimen for Patients With Relapse or Refractory B-cell Non-Hodgkin's Lymphoma (NHL)

This is a prospective phase II clinical trial to observe the efficacy and safety of Chidamide combined with DICE (Dexamethasone, Ifosfamide, Cisplatin and Etoposide) in patients with relap...

Study on the Combination Regimen of Dexamethasone Ifosfamide Cisplatin Etoposide in Patients With NK/T Cell Lymphoma

The purpose of this study is to evaluate the efficacy and tolerability of the combination chemotherapy of DICE in the patients with NK/T cell lymphoma.

Decitabine Based Chemotherapy Followed by Haploidentical Lymphocyte Infusion for Elderly Patients With AML

Demethylating agent decitabine enhances the immunogenicity of leukemia cells by inducing the expression of cancer testis antigens (CTAs),MHC class I and II molecules,costimulatory molecule...

Adherence to Dolutegravir and Outcome

The main assumption is that the dolutegravir can get virologic suppression to suboptimal adherence levels (between 80 and 95%, and after treatment interruptions) where other molecules are ...

Exploratory Study to Explore the Safety and Efficacy of the HDx Therapy Using Theranova 500 Dialyzer in Comparison to Hemodiafiltration

Today it is well established that middle molecules comprise several compounds that are not effectively removed by high-flux dialyzers, and effective clearance of large middle molecules in ...

Companies [403 Associated Companies listed on BioPortfolio]

DiCE Molecules SV, LLC

DiCE Molecules is a privately held company focused on the development of small molecule compounds that unlock previously intractable targets. DiCE’s platform uniquely brings ...


Diaclone produces a large panel of monoclonals antibodies and kits to detect human, mouse and rat molecules playing key roles in the immune system (CDs, cytokines and adhesion molecules.

Alchemie Limited

Alchemia has become internationally recognised for its unique platform technology for the production of complex sugar-based molecules called oligosaccharides.Oligosaccharides play pivotal roles in man...

Xenome Limited

Xenome aims to develop new treatments for pain, particularly intractable pain as experienced by many cancer patients, as well as other neurological conditions for which there is an unmet clinical need...


The Molecular Design and Discovery (MDD) Incorporated is a North American company with its headquarter located in Mississauga, Ontario, Canada. The company is service provider of advanced chemical an...

More Information about "DiCE Molecules SV, LLC" on BioPortfolio

We have published hundreds of DiCE Molecules SV, LLC news stories on BioPortfolio along with dozens of DiCE Molecules SV, LLC Clinical Trials and PubMed Articles about DiCE Molecules SV, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of DiCE Molecules SV, LLC Companies in our database. You can also find out about relevant DiCE Molecules SV, LLC Drugs and Medications on this site too.

Quick Search


Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Corporate Database Quicklinks

Searches Linking to this Company Record